Prostate cancer (PCa) patients who have the Endo180 protein present in their tumors tend to have a more aggressive form of the disease.
Obese men are at a greater risk of developing more advanced forms of prostate cancer (PCa).
Dual use of both drugs significantly reduced the risk of biochemical prostate cancer recurrence after radical surgery.
Diets rich in walnuts or walnut oils slow prostate cancer (PCa) tumor growth in mice.
Diagnostic usefulness of magnetic resonance imaging/ultrasound (MRI/US) fusion targeted prostate biopsy optimized in PSA level of 5.2 ng/mL or higher.
Scientists have discovered a way to "switch off" prostate cancer (PCa) cell production in mice with a thrice-weekly injection.
Androgen-deprivation therapy (ADT) for more than 1 year is associated with a 2.5 times higher odds of fracture in prostate cancer patients.
Greater PSA increases seen in older men and those with lower baseline testosterone.
Compared with noncarriers, BRCA carriers experience metastatic prostate cancer sooner and have shorter survival.
Guideline outlines use of adjuvant and salvage radiotherapy after surgery for prostate cancer.
AMACR enzyme is being developed to test the potential for prostate cancer drugs.
PSA levels at day 30 found to predict biochemical relapse risk in men with positive surgical margins.
Racial differences in prostate cancer (PCa) treatment regret more pronounced among those without sexual problems.
But overall risk of heart-related death risk from prostate cancer treatment is small, researchers say.
Men who have slept with more than 20 female partners are less likely to develop aggressive prostate cancer (PCa).
Patients who smoke during external beam radiotherapy (EBRT) are at increased risk of distant metastases and dying from prostate cancer.
Consuming ten portions of tomatoes a week can lower the risk of prostate cancer.
Significant association observed for high-risk prostate cancers with no difference according to daily dose.
Vitamin D may be able to suppress inflammation in prostate tissue by boosting expression of the GDF-15 gene.
Fathering of dizygotic twins, a marker of high fertility, was not associated with increased risk of prostate cancer.
New data confirms that ConfirmMDx, an epigenetic assay, is able to accurately identify prostate cancer aggressiveness
Testosterone replacement therapy (TRT) may promote prostate cancer tumor growth.
Abnormal triglyceride levels found to increase the post-radical prostatectomy risk of biochemical relapse by 35%.
Findings suggest that normalization of blood fats may reduce risk of prostate cancer.
Mortality was greater with external beam radiotherapy across treatment-specific nomograms for predicting biochemical recurrence.
Researchers confident in this approach because candidates for active surveillance are a heavily screened population.
A biomarker present on the KLK3 gene can predict which GS7 prostate cancer patients will be more aggressive.
Growth in robot-assisted radical prostatectomy (RARP) use especially pronounced among surgeons at urban hospitals.
Meta-analysis shows that the risk is increased 20% with each 20 cigarettes smoked per day.
Urologic complications requiring hospital admission grew from 3.6% in 2000 to 3.9% in 2008, largely because of infections.
- Optimal PSA Threshold For Targeted Biopsy Identified
- Plant-Based Phosphorus Best for Kidney Disease (CKD) Patients
- Testosterone Replacement Therapy (TRT) Beneficial in Diabetes Mellitus Patients
- Stopping Renal Cell Carcinoma (mRCC) Drugs Induces Tumor Flare
- Red Meat Contributes to Cardiovascular Disease (CVD) Risk Due to Gut Bacteria
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)